- Home
- Publications
- Publication Search
- Publication Details
Title
Can we cure hepatitis B virus with novel direct‐acting antivirals?
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 40, Issue S1, Pages 27-34
Publisher
Wiley
Online
2020-02-20
DOI
10.1111/liv.14364
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drugs in the Pipeline for HBV
- (2019) Uri Lopatin Clinics in Liver Disease
- FRI-184-Function and drug combination studies in cell culture models for AB-729, a subcutaneously administered siRNA investigational agent for chronic hepatitis B infection
- (2019) Amy C.H. Lee et al. JOURNAL OF HEPATOLOGY
- PS-080-Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold
- (2019) Man-Fung Yuen et al. JOURNAL OF HEPATOLOGY
- PS-074-A first-in-class orally available HBV cccDNA destabilizer ccc_R08 achieved sustainable HBsAg and HBV DNA suppression in the HBV circle mouse model through elimination of cccDNA-like molecules in the mouse liver
- (2019) Li Wang et al. JOURNAL OF HEPATOLOGY
- FRI-210-Establishment of high rates of functional cure of HBeAg negative chronic HBV infection with REP 2139-Mg based combination therapy: Ongoing follow-up results from the REP 401 study
- (2019) Michel Bazinet et al. JOURNAL OF HEPATOLOGY
- Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
- (2019) Masashi Iwamoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic strategies for hepatitis B virus infection: towards a cure
- (2019) Gregory C. Fanning et al. NATURE REVIEWS DRUG DISCOVERY
- Novel potent capsid assembly modulators regulate multiple steps of the Hepatitis B virus life-cycle
- (2018) Thomas Lahlali et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination treatment of a TLR7 agonist RO7020531and a capsid assembly modulator RO7049389 achieved sustainable viral loadsuppression and HBsAg loss in an AAV-HBV mouse model
- (2018) L. Dai et al. JOURNAL OF HEPATOLOGY
- Preclinical antiviral drug combination studies utilizing novel orally bioavailable investigational agents for chronic hepatitis B infection: AB-506, a next generation HBV capsid inhibitor, and AB-452, a HBV RNA destabilizer
- (2018) N. Mani et al. JOURNAL OF HEPATOLOGY
- Combinatorial RNAi/vaccination therapy for chronic hepatitis B achieves long-term functional cure in preclinical mouse model
- (2018) T. Michler et al. JOURNAL OF HEPATOLOGY
- A novel orally available small molecule that inhibits hepatitis B virus expression
- (2018) Henrik Mueller et al. JOURNAL OF HEPATOLOGY
- Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
- (2018) Kristie Bloom et al. Genes
- Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo
- (2018) Hassan Javanbakht et al. Molecular Therapy-Nucleic Acids
- Chemical Approaches to Inhibiting the Hepatitis B Virus Ribonuclease H
- (2018) John E. Tavis et al. ACS Infectious Diseases
- AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication In Vitro And In Vivo
- (2018) Hai-Bo Yu et al. International Journal of Medical Sciences
- Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo
- (2017) Lena Allweiss et al. GUT
- Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B
- (2017) Xupeng Hong et al. HEPATOLOGY
- Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
- (2017) Ching-Lung Lai et al. JOURNAL OF HEPATOLOGY
- Distribution of Hepatitis B Virus Nuclear DNA
- (2017) Mingming Li et al. JOURNAL OF VIROLOGY
- RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
- (2017) Christine I. Wooddell et al. Science Translational Medicine
- HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways
- (2017) Fang Guo et al. PLoS Pathogens
- Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients
- (2016) Anders Boyd et al. JOURNAL OF HEPATOLOGY
- Core protein: A pleiotropic keystone in the HBV lifecycle
- (2015) Adam Zlotnick et al. ANTIVIRAL RESEARCH
- HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
- (2015) Michael Nassal GUT
- HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase
- (2015) Lise Rivière et al. JOURNAL OF HEPATOLOGY
- Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
- (2014) Stephan Urban et al. GASTROENTEROLOGY
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started